Vanguard Group Inc Geron Corp Transaction History

Vanguard Group Inc

$5.37 Trillion
Q1 2025

A detailed history of Vanguard Group Inc transactions in Geron Corp stock. As of the latest transaction made, Vanguard Group Inc holds 34,146,851 shares of GERN stock, worth $51.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

34,146,851

Previous 33,538,822 1.81%

Holding current value

$51.9 Million

Previous $119 Million 54.27%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	BUY	$1.59 - $3.6 $966,766 - $2.19 Million	608,029 Added 1.81%	34,146,851 $54.3 Million
Q4 2024 Feb 11, 2025	BUY	$3.3 - $4.44 $3.59 Million - $4.83 Million	1,088,912 Added 3.36%	33,538,822 $119 Million
Q3 2024 Nov 13, 2024	BUY	$4.17 - $4.99 $2.15 Million - $2.58 Million	516,611 Added 1.62%	32,449,910 $147 Million
Q2 2024 Aug 13, 2024	BUY	$3.1 - $5.09 $6.4 Million - $10.5 Million	2,064,012 Added 6.91%	31,933,299 $135 Million
Q1 2024 May 10, 2024	BUY	$1.75 - $3.44 $2.28 Million - $4.49 Million	1,304,713 Added 4.57%	29,869,287 $98.6 Million
Q4 2023 Feb 14, 2024	BUY	$1.74 - $2.31 $3.33 Million - $4.42 Million	1,914,328 Added 7.18%	28,564,574 $60.3 Million
Q3 2023 Nov 14, 2023	SELL	$2.11 - $3.28 $69,602 - $108,197	-32,987 Reduced 0.12%	26,650,246 $56.5 Million
Q2 2023 Aug 14, 2023	BUY	$1.97 - $3.69 $8.16 Million - $15.3 Million	4,141,265 Added 18.37%	26,683,233 $85.7 Million
Q1 2023 May 15, 2023	BUY	$2.14 - $3.4 $7.71 Million - $12.2 Million	3,601,660 Added 19.02%	22,541,968 $48.9 Million
Q4 2022 Feb 10, 2023	BUY	$2.03 - $2.42 $1.41 Million - $1.68 Million	695,155 Added 3.81%	18,940,308 $45.8 Million
Q3 2022 Nov 14, 2022	SELL	$1.67 - $2.94 $2.48 Million - $4.37 Million	-1,485,000 Reduced 7.53%	18,245,153 $42.7 Million
Q2 2022 Aug 12, 2022	BUY	$1.19 - $1.65 $2.85 Million - $3.95 Million	2,393,223 Added 13.8%	19,730,153 $30.6 Million
Q1 2022 May 13, 2022	BUY	$0.99 - $1.6 $1.89 Million - $3.06 Million	1,910,182 Added 12.38%	17,336,930 $23.6 Million
Q4 2021 Feb 14, 2022	BUY	$1.22 - $1.72 $2,785 - $3,926	2,283 Added 0.01%	15,426,748 $18.8 Million
Q3 2021 Nov 12, 2021	SELL	$1.2 - $1.5 $291,451 - $364,314	-242,876 Reduced 1.55%	15,424,465 $21.1 Million
Q2 2021 Aug 13, 2021	BUY	$1.25 - $1.83 $19.6 Million - $28.7 Million	15,667,341 New	15,667,341 $22.1 Million

Others Institutions Holding GERN

# of Institutions

295

Shares Held

496M

Call Options Held

799K

Put Options Held

463K

View Full List

About GERON CORP

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $574M
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

More about GERN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Geron Corp Transaction History